Efficient differentiation of human induced pluripotent stem cells generates cardiac cells that provide protection following myocardial infarction in the rat.
Induced pluripotent stem (iPS) cells are being used increasingly to complement their embryonic counterparts to understand and develop the therapeutic potential of pluripotent cells. Our objectives were to identify an efficient cardiac differentiation protocol for human iPS cells as monolayers, and d...
| Автори: | , , , , , |
|---|---|
| Формат: | Journal article |
| Мова: | English |
| Опубліковано: |
2012
|
| _version_ | 1826271811579412480 |
|---|---|
| author | Carpenter, L Carr, C Yang, C Stuckey, D Clarke, K Watt, S |
| author_facet | Carpenter, L Carr, C Yang, C Stuckey, D Clarke, K Watt, S |
| author_sort | Carpenter, L |
| collection | OXFORD |
| description | Induced pluripotent stem (iPS) cells are being used increasingly to complement their embryonic counterparts to understand and develop the therapeutic potential of pluripotent cells. Our objectives were to identify an efficient cardiac differentiation protocol for human iPS cells as monolayers, and demonstrate that the resulting cardiac progenitors could provide a therapeutic benefit in a rodent model of myocardial infarction. Herein, we describe a 14-day protocol for efficient cardiac differentiation of human iPS cells as a monolayer, which routinely yielded a mixed population in which over 50% were cardiomyocytes, endothelium, or smooth muscle cells. When differentiating, cardiac progenitors from day 6 of this protocol were injected into the peri-infarct region of the rat heart; after coronary artery ligation and reperfusion, we were able to show that human iPS cell-derived cardiac progenitor cells engrafted, differentiated into cardiomyocytes and smooth muscle, and persisted for at least 10 weeks postinfarct. Hearts injected with iPS-derived cells showed a nonsignificant trend toward protection from decline in function after myocardial infarction, as assessed by magnetic resonance imaging at 10 weeks, such that the ejection fraction at 10 weeks in iPS treated hearts was 62%±4%, compared to that of control infarcted hearts at 45%±9% (P<0.2). In conclusion, we demonstrated efficient cardiac differentiation of human iPS cells that gave rise to progenitors that were retained within the infarcted rat heart, and reduced remodeling of the heart after ischemic damage. |
| first_indexed | 2024-03-06T22:02:37Z |
| format | Journal article |
| id | oxford-uuid:4f1a8954-a148-487e-9261-13ef084628d7 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T22:02:37Z |
| publishDate | 2012 |
| record_format | dspace |
| spelling | oxford-uuid:4f1a8954-a148-487e-9261-13ef084628d72022-03-26T16:05:06ZEfficient differentiation of human induced pluripotent stem cells generates cardiac cells that provide protection following myocardial infarction in the rat.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:4f1a8954-a148-487e-9261-13ef084628d7EnglishSymplectic Elements at Oxford2012Carpenter, LCarr, CYang, CStuckey, DClarke, KWatt, SInduced pluripotent stem (iPS) cells are being used increasingly to complement their embryonic counterparts to understand and develop the therapeutic potential of pluripotent cells. Our objectives were to identify an efficient cardiac differentiation protocol for human iPS cells as monolayers, and demonstrate that the resulting cardiac progenitors could provide a therapeutic benefit in a rodent model of myocardial infarction. Herein, we describe a 14-day protocol for efficient cardiac differentiation of human iPS cells as a monolayer, which routinely yielded a mixed population in which over 50% were cardiomyocytes, endothelium, or smooth muscle cells. When differentiating, cardiac progenitors from day 6 of this protocol were injected into the peri-infarct region of the rat heart; after coronary artery ligation and reperfusion, we were able to show that human iPS cell-derived cardiac progenitor cells engrafted, differentiated into cardiomyocytes and smooth muscle, and persisted for at least 10 weeks postinfarct. Hearts injected with iPS-derived cells showed a nonsignificant trend toward protection from decline in function after myocardial infarction, as assessed by magnetic resonance imaging at 10 weeks, such that the ejection fraction at 10 weeks in iPS treated hearts was 62%±4%, compared to that of control infarcted hearts at 45%±9% (P<0.2). In conclusion, we demonstrated efficient cardiac differentiation of human iPS cells that gave rise to progenitors that were retained within the infarcted rat heart, and reduced remodeling of the heart after ischemic damage. |
| spellingShingle | Carpenter, L Carr, C Yang, C Stuckey, D Clarke, K Watt, S Efficient differentiation of human induced pluripotent stem cells generates cardiac cells that provide protection following myocardial infarction in the rat. |
| title | Efficient differentiation of human induced pluripotent stem cells generates cardiac cells that provide protection following myocardial infarction in the rat. |
| title_full | Efficient differentiation of human induced pluripotent stem cells generates cardiac cells that provide protection following myocardial infarction in the rat. |
| title_fullStr | Efficient differentiation of human induced pluripotent stem cells generates cardiac cells that provide protection following myocardial infarction in the rat. |
| title_full_unstemmed | Efficient differentiation of human induced pluripotent stem cells generates cardiac cells that provide protection following myocardial infarction in the rat. |
| title_short | Efficient differentiation of human induced pluripotent stem cells generates cardiac cells that provide protection following myocardial infarction in the rat. |
| title_sort | efficient differentiation of human induced pluripotent stem cells generates cardiac cells that provide protection following myocardial infarction in the rat |
| work_keys_str_mv | AT carpenterl efficientdifferentiationofhumaninducedpluripotentstemcellsgeneratescardiaccellsthatprovideprotectionfollowingmyocardialinfarctionintherat AT carrc efficientdifferentiationofhumaninducedpluripotentstemcellsgeneratescardiaccellsthatprovideprotectionfollowingmyocardialinfarctionintherat AT yangc efficientdifferentiationofhumaninducedpluripotentstemcellsgeneratescardiaccellsthatprovideprotectionfollowingmyocardialinfarctionintherat AT stuckeyd efficientdifferentiationofhumaninducedpluripotentstemcellsgeneratescardiaccellsthatprovideprotectionfollowingmyocardialinfarctionintherat AT clarkek efficientdifferentiationofhumaninducedpluripotentstemcellsgeneratescardiaccellsthatprovideprotectionfollowingmyocardialinfarctionintherat AT watts efficientdifferentiationofhumaninducedpluripotentstemcellsgeneratescardiaccellsthatprovideprotectionfollowingmyocardialinfarctionintherat |